{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:03:10Z","timestamp":1793462590006,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2019,2,5]]},"DOI":"10.1007\/s40261-018-0729-y","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T01:47:16Z","timestamp":1542764836000},"page":"205-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone\/Corticosteroid Therapy: Population-Based Nested Case\u2013Control Study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0063-8069","authenticated-orcid":false,"given":"Daniel R","family":"Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Slattery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Pacurariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"McGettigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"issue":"10","key":"729_CR1","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s40261-018-0684-7","volume":"38","author":"DR Morales","year":"2018","unstructured":"Morales DR, Slattery J, Pinheiro L, Kurz X, Hedenmalm K. Indications for systemic fluoroquinolone therapy in Europe and prevalence of primary-care prescribing in France, Germany and the UK: descriptive population-based study. Clin Drug Investig. 2018;38(10):927\u201333.","journal-title":"Clin Drug Investig."},{"key":"729_CR2","unstructured":"Ciproxin 500\u00a0mg tablet summary of product characteristics. https:\/\/www.medicines.org.uk\/emc\/product\/6153\/smpc. Accessed 06 July 2018."},{"issue":"11","key":"729_CR3","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1086\/375078","volume":"36","author":"Y Khaliq","year":"2003","unstructured":"Khaliq Y, Zhanel GG. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis. 2003;36(11):1404\u201310.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"729_CR4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s10067-003-0758-6","volume":"22","author":"R Ozaras","year":"2003","unstructured":"Ozaras R, Mert A, Tahan V, Uraz S, Ozaydin I, Yilmaz MH, Ozaras N. Ciprofloxacin and Achilles\u2019 tendon rupture: a causal relationship. Clin Rheumatol. 2003;22(6):500\u20131.","journal-title":"Clin Rheumatol"},{"key":"729_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003674.pub4","author":"RJ Khan","year":"2010","unstructured":"Khan RJ, Carey Smith RL. Surgical interventions for treating acute Achilles tendon ruptures. Cochrane Database Syst Rev. 2010. https:\/\/doi.org\/10.1002\/14651858.CD003674.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"729_CR6","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1177\/0363546514540599","volume":"42","author":"TT Huttunen","year":"2014","unstructured":"Huttunen TT, Kannus P, Rolf C, Fellander-Tsai L, Mattila VM. Acute Achilles tendon ruptures: incidence of injury and surgery in Sweden between 2001 and 2012. Am J Sports Med. 2014;42:2419\u201323.","journal-title":"Am J Sports Med"},{"issue":"3","key":"729_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00042752-199907000-00007","volume":"9","author":"N Maffulli","year":"1999","unstructured":"Maffulli N, Waterston SW, Squair J, Reaper J, Douglas AS. Changing incidence of Achilles tendon rupture in Scotland: a 15-year study. Clin J Sport Med. 1999;9(3):157\u201360.","journal-title":"Clin J Sport Med"},{"issue":"8","key":"729_CR8","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1177\/0363546515587738","volume":"43","author":"MP Kelly","year":"2015","unstructured":"Kelly MP, Perkinson SG, Ablove RH, Tueting JL. Distal biceps tendon ruptures: an epidemiological analysis using a large population database. Am J Sports Med. 2015;43(8):2012\u20137.","journal-title":"Am J Sports Med"},{"key":"729_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/jor.21196","volume":"29","author":"WC Tsai","year":"2011","unstructured":"Tsai WC, Hsu CC, Chen CP, et al. Ciprofloxacin up-regulates tendon cells to express matrix metalloproteinase-2 with degradation of type I collagen. J Orthop Res. 2011;29:67\u201373.","journal-title":"J Orthop Res"},{"issue":"12","key":"729_CR10","doi-asserted-by":"publisher","first-page":"1228.e23","DOI":"10.1016\/j.amjmed.2012.05.027","volume":"125","author":"BL Wise","year":"2012","unstructured":"Wise BL, Peloquin C, Choi H, Lane NE, Zhang Y. Impact of age, sex, obesity, and steroid use on quinolone-associated tendon disorders. Am J Med. 2012;125(12):1228.e23\u20138.","journal-title":"Am J Med"},{"key":"729_CR11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/036354658901700305","volume":"17","author":"L J\u00f3zsa","year":"1989","unstructured":"J\u00f3zsa L, Kvist M, B\u00e1lint BJ, Reffy A, J\u00e4rvinen M, Lehto M, Barzo M. The role of recreational sport activity in Achilles tendon rupture. A clinical, pathoanatomical, and sociological study of 292 cases. Am J Sports Med. 1989;17:338\u201343.","journal-title":"Am J Sports Med"},{"key":"729_CR12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jdiacomp.2016.02.017","volume":"30","author":"J Spoendlin","year":"2016","unstructured":"Spoendlin J, Meier C, Jick SS, Meier CR. Achilles or biceps tendon rupture in women and men with type 2 diabetes: a population-based case\u2013control study. J Diabetes Complicat. 2016;30:903\u20139.","journal-title":"J Diabetes Complicat"},{"issue":"3","key":"729_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1056\/NEJM199501193320319","volume":"332","author":"A Szarfman","year":"1995","unstructured":"Szarfman A, Chen M, Blum MD. More on fluoroquinolone antibiotics and tendon rupture. N Engl J Med. 1995;332(3):193.","journal-title":"N Engl J Med"},{"key":"729_CR14","unstructured":"FDA drug safety communication (online). July 2016. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm500143.htm. Accessed 17 Jan 2017."},{"key":"729_CR15","unstructured":"European Medicines Agency. Quinolone and fluoroquinolone article 31 referral. 2017. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/referrals\/Quinolones_and_fluoroquinolones_containing_medicinal_products\/human_referral_prac_000065.jsp&mid=WC0b01ac05805c516f. Accessed 01 Sept 2017."},{"issue":"7349","key":"729_CR16","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1136\/bmj.324.7349.1306","volume":"324","author":"PD van der Linden","year":"2002","unstructured":"van der Linden PD, Sturkenboom MC, Herings RM, Leufkens HG, Stricker BH. Fluoroquinolones and risk of Achilles tendon disorders: case\u2013control study. BMJ. 2002;324(7349):1306\u20137.","journal-title":"BMJ"},{"issue":"15","key":"729_CR17","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1001\/archinte.163.15.1801","volume":"163","author":"PD van der Linden","year":"2003","unstructured":"van der Linden PD, Sturkenboom MC, Herings RM, Leufkens HM, Rowlands S, Stricker BH. Increased risk of achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med. 2003;163(15):1801\u20137.","journal-title":"Arch Intern Med"},{"issue":"5","key":"729_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00228-007-0265-9","volume":"63","author":"J Sode","year":"2007","unstructured":"Sode J, Obel N, Hallas J, Lassen A. Use of fluroquinolone and risk of Achilles tendon rupture: a population-based cohort study. Eur J Clin Pharmacol. 2007;63(5):499\u2013503.","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"729_CR19","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2165\/00002018-200629100-00006","volume":"29","author":"G Corrao","year":"2006","unstructured":"Corrao G, Zambon A, Bert\u00f9 L, Mauri A, Paleari V, Rossi C, Venegoni M. Evidence of tendinitis provoked by fluoroquinolone treatment: a case\u2013control study. Drug Saf. 2006;29(10):889\u201396.","journal-title":"Drug Saf"},{"issue":"11","key":"729_CR20","doi-asserted-by":"publisher","first-page":"e010077","DOI":"10.1136\/bmjopen-2015-010077","volume":"5","author":"N Daneman","year":"2015","unstructured":"Daneman N, Lu H, Redelmeier DA. Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study. BMJ Open. 2015;5(11):e010077.","journal-title":"BMJ Open"},{"key":"729_CR21","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/pds.1214","volume":"15","author":"JD Seeger","year":"2006","unstructured":"Seeger JD, West WA, Fife D, Noel GJ, Johnson LN, Walker AM. Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population. Pharmacoepidemiol Drug Saf. 2006;15:784\u201392.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"729_CR22","first-page":"251","volume":"19","author":"BT Blak","year":"2011","unstructured":"Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care. 2011;19(4):251\u20135.","journal-title":"Inform Prim Care"},{"key":"729_CR23","unstructured":"Health and Social Care Information Centre. Read codes. http:\/\/systems.hscic.gov.uk\/data\/uktc\/readcodes. Accessed 1 Sept 2015."},{"issue":"4","key":"729_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/pds.1335","volume":"16","author":"JD Lewis","year":"2007","unstructured":"Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2007;16(4):393\u2013401.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"729_CR25","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1592\/phco.24.11.964.36143","volume":"24","author":"M Etminan","year":"2004","unstructured":"Etminan M, Samii A. Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs. Pharmacotherapy. 2004;24:964\u20139.","journal-title":"Pharmacotherapy"},{"key":"729_CR26","unstructured":"Joint Formulary Committee. British National Formulary (online) London: BMJ Group and Pharmaceutical Press. http:\/\/www.medicinescomplete.com. Accessed 16 Oct 2016."},{"key":"729_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"729_CR28","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/EDE.0000000000000221","volume":"26","author":"S Suissa","year":"2015","unstructured":"Suissa S. The Quasi-cohort approach in pharmacoepidemiology: upgrading the nested case\u2013control. Epidemiology. 2015;26:242\u20136.","journal-title":"Epidemiology"},{"key":"729_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/0962280206074463","volume":"16","author":"S van Buuren","year":"2007","unstructured":"van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16:219\u201342.","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"729_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/art.23309","volume":"59","author":"I Marie","year":"2008","unstructured":"Marie I, Delafen\u00eatre H, Massy N, Thuillez C, Noblet C, Network of the French Pharmacovigilance Centers. Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990\u20132005 and review of the literature. Arthritis Rheum. 2008;59(3):367\u201372.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"729_CR31","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s40264-016-0462-5","volume":"39","author":"J Spoendlin","year":"2016","unstructured":"Spoendlin J, Layton JB, Mundkur M, Meier C, Jick SS, Meier CR. The risk of Achilles or biceps tendon rupture in new statin users: a propensity score-matched sequential cohort study. Drug Saf. 2016;39(12):1229\u201337.","journal-title":"Drug Saf"},{"issue":"5","key":"729_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/MJT.0000000000000039","volume":"22","author":"T Contractor","year":"2015","unstructured":"Contractor T, Beri A, Gardiner JC, Tang X, Dwamena FC. Is statin use associated with tendon rupture? A population-based retrospective cohort analysis. Am J Ther. 2015;22(5):377\u201381.","journal-title":"Am J Ther"},{"issue":"5","key":"729_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/FJC.0b013e3181a0ce8b","volume":"53","author":"A Beri","year":"2009","unstructured":"Beri A, Dwamena FC, Dwamena BA. Association between statin therapy and tendon rupture: a case\u2013control study. J Cardiovasc Pharmacol. 2009;53(5):401\u20134.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"10","key":"729_CR34","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/cea.12971","volume":"47","author":"CJ Weatherburn","year":"2017","unstructured":"Weatherburn CJ, Guthrie B, Mercer SW, Morales DR. Comorbidities in adults with asthma: population-based cross-sectional analysis of 1.4 million adults in Scotland. Clin Exp Allergy. 2017;47(10):1246\u201352.","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"729_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12916-017-0781-0","volume":"15","author":"DR Morales","year":"2017","unstructured":"Morales DR, Lipworth BJ, Donnan PT, Jackson C, Guthrie B. Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study. BMC Med. 2017;15(1):18.","journal-title":"BMC Med"},{"issue":"658","key":"729_CR36","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.3399\/bjgp17X690605","volume":"67","author":"U Chetty","year":"2017","unstructured":"Chetty U, McLean G, Morrison D, Agur K, Guthrie B, Mercer SW. Chronic obstructive pulmonary disease and comorbidities: a large cross-sectional study in primary care. Br J Gen Pract. 2017;67(658):e321\u20138.","journal-title":"Br J Gen Pract"},{"issue":"14","key":"729_CR37","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1212\/WNL.0000000000000846","volume":"83","author":"M Etminan","year":"2014","unstructured":"Etminan M, Brophy JM, Samii A. Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study. Neurology. 2014;83(14):1261\u20133.","journal-title":"Neurology"},{"issue":"12","key":"729_CR38","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jacc.2018.06.067","volume":"72","author":"CC Lee","year":"2018","unstructured":"Lee CC, Lee MG, Hsieh R, Porta L, Lee WC, Lee SH, Chang SS. Oral fluoroquinolone and the risk of aortic dissection. J Am Coll Cardiol. 2018;72(12):1369\u201378.","journal-title":"J Am Coll Cardiol"},{"issue":"360","key":"729_CR39","doi-asserted-by":"publisher","first-page":"k678","DOI":"10.1136\/bmj.k678","volume":"8","author":"B Pasternak","year":"2018","unstructured":"Pasternak B, Inghammar M, Svanstr\u00f6m H. Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study. BMJ. 2018;8(360):k678.","journal-title":"BMJ"},{"issue":"11","key":"729_CR40","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1001\/jamainternmed.2015.5389","volume":"175","author":"CC Lee","year":"2015","unstructured":"Lee CC, Lee MT, Chen YS, Lee SH, Chen YS, Chen SC, Chang SC. Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone. JAMA Intern Med. 2015;175(11):1839\u201347.","journal-title":"JAMA Intern Med"}],"updated-by":[{"DOI":"10.1007\/s40261-019-00755-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000}},{"DOI":"10.1007\/s40261-019-00792-7","type":"addendum","label":"Addendum","source":"publisher","updated":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000}}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-018-0729-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-018-0729-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-018-0729-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T12:45:16Z","timestamp":1627649116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-018-0729-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,5]]}},"alternative-id":["729"],"URL":"https:\/\/doi.org\/10.1007\/s40261-018-0729-y","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"assertion":[{"value":"21 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40261-019-00755-y","URL":"https:\/\/doi.org\/10.1007\/s40261-019-00755-y","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No source of funding\u00a0was used for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval to conduct the studies using anonymised data was granted by the Scientific Review Committees of The Health Improvement Network (Protocol number 17THIN087).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The views expressed in this article are the personal views of the author(s) and may not be not be understood or quoted as reflecting the views of the EMA or one of its committees or working parties.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"All authors were involved in the study design and data collection. DM performed the analysis and is guarantor for the study. All authors contributed to the interpretation of results and writing the manuscript, and approved the final draft.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author\u00a0Contributions"}}]}}